🇪🇺 UPC
UPC_CFI_195/2025
Court
Düsseldorf Local Division
Type of action
infringement
Patent
METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
Language
en
Claimant / applicant
- Sanofi Biotechnologies SAS
- Regeneron Pharmaceuticals Inc.
Defendant / respondent
- Amgen Inc.
- Amgen GmbH
- Amgen S.A.S.
- Amgen Inc., One Amgen Center Drive
- Amgen Europe B.V.
- Amgen N.V.
- Amgen B.V.
- Amgen S.R.L.
Track this case
Get an email when a new order or decision is published in UPC_CFI_195/2025.
Decisions and documents (1)
- 2026-06-08procedural
- Claimants:
- Regeneron Pharmaceuticals Inc.; Sanofi Biotechnologies SAS
- Defendants:
- Amgen B.V.; Amgen Europe B.V.; Amgen GmbH; Amgen Inc.; Amgen N.V.; Amgen S.A.S.; Amgen S.R.L.
Infringement Action. Document: 2025-06-08 Order Withdrawal_BT_signed_XDG_AK_IR_LD (1).pdf. Case page: https://www.unifiedpatentcourt.org/en/node/183435
Judge: Dr Thom • Panel: Dr Rinken
Weekly digest
A weekly email summarising new published decisions across European patent courts.